ANTX Latest Press Releases

-- March 17, 2026 --

AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights Business Wire 4:00 PM

-- March 9, 2026 --

AN2 Therapeutics Announces $40 Million Private Placement Financing Business Wire 7:00 AM

-- March 3, 2026 --

AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) Business Wire 4:00 PM

-- February 17, 2026 --

AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference Business Wire 7:00 AM

-- January 12, 2026 --

AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease Business Wire 7:00 AM

-- November 12, 2025 --

AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights Business Wire 4:01 PM

-- November 10, 2025 --

AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB) Business Wire 7:00 AM

-- November 6, 2025 --

AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference Business Wire 5:03 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software